glp-1 stomach paralysis class action in louisiana semaglutide legal team Companies making Ozempic and Mounjaro sued over 'stomach paralysis' claims Ozempic Claim Eligibility for Injured – Louisiana spent over $1B on

Galvin SG, Kay RG, Foreman R et al (2021) The human and mouse islet peptidome: effects of obesity and type 2 diabetes, and assessment of intraislet production of glucagon-like peptide-1

3 In July 2018, the manufacturer removed albiglutide from the market due to financial reasons

Elevated levels promote deep belly fat storage (visceral fat) and increase appetite

Rapid weight loss with GLP1 receptor agonists can come at the cost of skeletal muscle, potentially undermining metabolic and functional outcomes

Always consult your GP before making changes to prescribed diabetes or weight management treatments

Atypical features, such as blood in the urine, rapid kidney decline, sudden heavy protein loss, or symptoms that do not fit diabetes-related disease, may lead clinicians to look for other causes